In Depth

Featured article

The US manufacturing comeback

Also in this section

NAMs move into the mainstream

Not made in China: US presses on with pharma security agenda

AI tools bridging preclinical to FIH are now a necessity, not a nice to have

Data first: AI governance a fundamental pillar in the hospital pharmacy

ASCO26: AI innovations show promise in reducing the oncology RWD burden

The celebrity prescription: star power meets healthcare

AI in oncology: trials, tribulations and future opportunities